STUDY OBJECTIVE: Previously, we used a proteomics approach for the discovery of new diagnostic markers of acute appendicitis and identified leucine-rich α-2-glycoprotein (LRG) that was elevated in the urine of children with acute appendicitis and enriched in diseased appendices. Here, we sought to evaluate the diagnostic utility of enzyme-linked immunosorbent assay (ELISA) of urine LRG in a blinded, prospective, cohort study of children being evaluated for acute abdominal pain. METHODS: Urine LRG concentration was measured with a commercially available LRG ELISA and selected ion monitoring mass spectrometry. Urine LRG test performance was evaluated blindly against the pathologic diagnosis and histologic grade of appendicitis. RESULTS: Urine LRG was measured in 49 patients. Mean urine LRG concentration measured with commercial LRG ELISA was significantly elevated in patients with acute appendicitis but exhibited an interference effect. Direct measurements using selected ion monitoring mass spectrometry demonstrated that LRG was elevated more than 100-fold in patients with acute appendicitis compared with those without, with the receiver operating characteristic area under the curve of 0.98 (95% confidence interval 0.96 to 1.0). Among patients with acute appendicitis, elevations of urine LRG measured with ELISA and selected ion monitoring mass spectrometry correlated with the histologic severity of appendicitis. CONCLUSION: Urine LRG ELISA allows for discrimination between patients with and without acute appendicitis but exhibits limited accuracy because of immunoassay interference. Direct measurements of urine LRG with selected ion monitoring mass spectrometry demonstrate superior diagnostic performance. Development of a clinical-grade urine LRG assay is needed to advance the diagnostic accuracy of clinical evaluations of appendicitis.
STUDY OBJECTIVE: Previously, we used a proteomics approach for the discovery of new diagnostic markers of acute appendicitis and identified leucine-rich α-2-glycoprotein (LRG) that was elevated in the urine of children with acute appendicitis and enriched in diseased appendices. Here, we sought to evaluate the diagnostic utility of enzyme-linked immunosorbent assay (ELISA) of urine LRG in a blinded, prospective, cohort study of children being evaluated for acute abdominal pain. METHODS: Urine LRG concentration was measured with a commercially available LRG ELISA and selected ion monitoring mass spectrometry. Urine LRG test performance was evaluated blindly against the pathologic diagnosis and histologic grade of appendicitis. RESULTS: Urine LRG was measured in 49 patients. Mean urine LRG concentration measured with commercial LRG ELISA was significantly elevated in patients with acute appendicitis but exhibited an interference effect. Direct measurements using selected ion monitoring mass spectrometry demonstrated that LRG was elevated more than 100-fold in patients with acute appendicitis compared with those without, with the receiver operating characteristic area under the curve of 0.98 (95% confidence interval 0.96 to 1.0). Among patients with acute appendicitis, elevations of urine LRG measured with ELISA and selected ion monitoring mass spectrometry correlated with the histologic severity of appendicitis. CONCLUSION: Urine LRG ELISA allows for discrimination between patients with and without acute appendicitis but exhibits limited accuracy because of immunoassay interference. Direct measurements of urine LRG with selected ion monitoring mass spectrometry demonstrate superior diagnostic performance. Development of a clinical-grade urine LRG assay is needed to advance the diagnostic accuracy of clinical evaluations of appendicitis.
Authors: John M Howell; Orin L Eddy; Thomas W Lukens; Molly E W Thiessen; Scott D Weingart; Wyatt W Decker Journal: Ann Emerg Med Date: 2010-01 Impact factor: 5.721
Authors: Andrea S Doria; Rahim Moineddin; Christian J Kellenberger; Monica Epelman; Joseph Beyene; Suzanne Schuh; Paul S Babyn; Paul T Dick Journal: Radiology Date: 2006-08-23 Impact factor: 11.105
Authors: David G Bundy; Julie S Byerley; E Allen Liles; Eliana M Perrin; Jessica Katznelson; Henry E Rice Journal: JAMA Date: 2007-07-25 Impact factor: 56.272
Authors: Alex Kentsis; Yin Yin Lin; Kyle Kurek; Monica Calicchio; Yan Yan Wang; Flavio Monigatti; Fabien Campagne; Richard Lee; Bruce Horwitz; Hanno Steen; Richard Bachur Journal: Ann Emerg Med Date: 2009-06-25 Impact factor: 5.721
Authors: Ann M Kolbach-Mandel; Neil S Mandel; Brian R Hoffmann; Jack G Kleinman; Jeffrey A Wesson Journal: Urolithiasis Date: 2017-03-17 Impact factor: 3.436
Authors: Quan Hong; Lu Zhang; Jia Fu; Divya A Verghese; Kinsuk Chauhan; Girish N Nadkarni; Zhengzhe Li; Wenjun Ju; Matthias Kretzler; Guang-Yan Cai; Xiang-Mei Chen; Vivette D D'Agati; Steven G Coca; Detlef Schlondorff; John C He; Kyung Lee Journal: J Am Soc Nephrol Date: 2019-03-11 Impact factor: 10.121
Authors: Jan Muntel; Yue Xuan; Sebastian T Berger; Lukas Reiter; Richard Bachur; Alex Kentsis; Hanno Steen Journal: J Proteome Res Date: 2015-10-22 Impact factor: 4.466
Authors: Saima Ahmed; Oludare A Odumade; Patrick van Zalm; Kinga K Smolen; Kimino Fujimura; Jan Muntel; Melissa S Rotunno; Abigail B Winston; Judith A Steen; Richard B Parad; Linda J Van Marter; Stella Kourembanas; Hanno Steen Journal: Neonatology Date: 2022-01-24 Impact factor: 4.035
Authors: Michael V Ortiz; Saima Ahmed; Melissa Burns; Anton G Henssen; Travis J Hollmann; Ian MacArthur; Shehana Gunasekera; Lyvia Gaewsky; Gary Bradwin; Jeremy Ryan; Anthony Letai; Ying He; Arlene Naranjo; Yueh-Yun Chi; Michael LaQuaglia; Todd Heaton; Paolo Cifani; Jeffrey S Dome; Samantha Gadd; Elizabeth Perlman; Elizabeth Mullen; Hanno Steen; Alex Kentsis Journal: JCI Insight Date: 2019-08-08